Erasca, Inc. 4

Charles S. Fuchs, President, R&D of Erasca, Inc., was granted stock options for 1,300,000 shares of common stock at an exercise price of $18.12 per share.

On August 10, 2026, Charles S. Fuchs, President, R&D of Erasca, Inc., received a stock option award covering 1,300,000 shares of Erasca common stock at an exercise price of $18.12 per share, granted in connection with his commencement of employment. The option, which consists of both incentive and nonqualified stock option components under the company’s 2021 Incentive Award Plan and 2026 Employment Inducement Incentive Award Plan, vests 25% on the first anniversary of the grant date and the remaining 75% in 36 substantially equal monthly installments thereafter, contingent on continued service. Following this grant, Fuchs holds derivative securities representing 1,300,000 shares of common stock. Using the exercise price as a proxy for value, the award represents an option value reference of approximately $23.6 million in underlying share value, with the same figure used to approximate the value of his post-grant derivative holdings.

Filing Facts

CIK

1761918

Ticker

ERAS

Form

4

Source Type

fda

Accession

0001193125-26-346924

Alert Tier

7